| Prev Close | 1.20 |
| Day Low/High | 1.05 / 1.28 |
| 52 Wk Low/High | 0.90 / 4.78 |
| Avg Volume | 640.80K |
| Exchange | NASDAQ |
| Shares Outstanding | 27.75M |
| Market Cap | 33.30M |
| EPS | -1.00 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cancer Genetics, Inc.
Glancy Prongay & Murray LLP ("GPM") continues its investigation on behalf of Cancer Genetics, Inc.
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Cancer Genetics, Inc.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Cancer Genetics, Inc.
Conference call at 4:30 p.m. EDT, Monday, April 2, 2018
Conference call at 4:30 p.m. EDT, Monday, April 2, 2018
LD Micro Main Event and Benchmark Micro Cap Conference
Founder of Multiple Successful Biotech Companies Including Actelion Pharmaceuticals, Sold to Johnson & Johnson for $30 Billion
Company Also Increased Number of Clinical Trials and Studies it Supports to 191, up 59%
Conference call scheduled for Tuesday, August 22, 2017- 8:30 AM Eastern
